Clinical Trial Update: Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression [NA]

View source ↗

Summary

A clinical trial investigating flavanol augmentation as a treatment strategy for antidepressant non-response in late-life depression was terminated, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Flavanol augmentation

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Depression, Major Depressive Disorder | NA | Status: TERMINATED | Results posted: 2019-09-06